@misc{misc585423b7,
title   = {Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4},
author = {Bachelot, T and Royce, M and Villanueva, C and Cruz, F. Melo and Hegg, Roberto and Falkson, C and Jeong, J and Srimuninnimit, V and Arce, C. H and Ridolfi, A},
year = {2017},
booktitle   = {42nd European-Society-for-Medical-Oncology Congress (ESMO)}
}